Forecast: Pharmaceutical Preparations Turnover in the Netherlands

Analyzing the pharmaceutical preparations turnover in the Netherlands for the period from 2024 to 2028, we observe a steady upward trend. The turnover is expected to increase year-over-year from 7.11 billion Euros in 2024 to 7.33 billion Euros in 2028. Comparing to the actual turnover in 2023, which was 7.05 billion Euros, we see a consistent growth pattern. The year-on-year variation indicates incremental but stable growth rates: 0.6% from 2024 to 2025, 0.8% from 2025 to 2026, 0.8% from 2026 to 2027, and 0.7% from 2027 to 2028. The Compound Annual Growth Rate (CAGR) over the next five years is approximately 0.8%, suggesting a modest but continuous increase in the sector.

Future trends to watch for in this sector include the impact of technological advancements in drug development, government healthcare policies, and demographic changes such as aging populations. Additionally, global economic factors and potential regulatory changes in the European Union will also play a crucial role in shaping the market dynamics.